IRLAB Therapeutics is a Swedish biopharmaceutical company based in Gothenburg that discovers and develops new medicines for Parkinson's disease. Its work centres on drug candidates that target symptoms and complications of the condition, including movement problems and cognitive difficulties, and it advances these programmes through clinical testing. The company carries out its own research and development and works with partners and clinical investigators to study its compounds in patients.
The shares are listed on the Stockholm Exchange in Sweden under the code IRLAB-A, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #268 of 911 on the Stockholm Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendStrong
81/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average27.8%
From 52-week high-21.6%
MomentumStrong
70/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return49.0%
6-month return33.3%
12-month, skipping last month-34.3%
Stability (higher is calmer)Weak
41/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)50.9%
Worst drawdown, 1 year (smaller is calmer)-53.6%
LiquidityFair
66/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.01M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 1.145 – 2.720Daily closes, split-adjusted
Signals
50-day average1.784
200-day average1.550
Golden/death cross (60d)Golden, 21 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.110
Technical summary
Daily
Strongly bullish
12 bullish · 3 neutral · 1 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
1.87
Bullish
EMA 10
1.90
Bullish
SMA 20
1.85
Bullish
EMA 20
1.86
Bullish
SMA 50
1.78
Bullish
EMA 50
1.76
Bullish
SMA 100
1.54
Bullish
EMA 100
1.66
Bullish
SMA 200
1.55
Bullish
EMA 200
1.95
Bullish
Oscillators (daily)
RSI (14)
63.03
Neutral
MACD (12, 26)
0.05
Bullish
Momentum (12)
8.54
Bullish
Stochastic %K (14)
78.33
Neutral
Williams %R (14)
-21.67
Neutral
CCI (20)
188.0
Bearish
Pivot points (classic, last session)
S3
1.79
S2
1.86
S1
1.92
Pivot
1.99
R1
2.05
R2
2.12
R3
2.18
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
